Scientific Sessions 2025  /  Inflammation and Atherosclerosis: Smoldering Threat or Therapeutic Target?  /  Debate- Colchicine for ASCVD: A Game-Changer or a Niche Therapy? Colchicine – ready for prime time
Logo

American Heart Association

  35
  0

Final ID:

Debate- Colchicine for ASCVD: A Game-Changer or a Niche Therapy? Colchicine – ready for prime time

  • Mehta, Anurag  ( Virginia Commonwealth University , Glen Allen , Virginia , United States )
  • Blaha, Michael  ( JOHNS HOPKINS HOSPITAL , Baltimore , Maryland , United States )
  • Budoff, Matthew  ( LUNDQUIST INSTITUTE , Torrance , California , United States )
    • Author Disclosures:
    Anurag Mehta: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amgen:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Active (exists now) | Michael Blaha: DO have relevant financial relationships ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now) ; Consultant:Eli Lilly:Past (completed) ; Consultant:Boehringer Ingelheim:Past (completed) ; Consultant:Astra Zeneca:Past (completed) ; Consultant:New Amsterdam:Active (exists now) ; Consultant:Agepha:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Idorsia:Past (completed) ; Consultant:Genentech:Past (completed) ; Consultant:Bayer:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Research Funding (PI or named investigator):Bayer:Active (exists now) | Matthew Budoff: DO have relevant financial relationships ; Researcher:Lilly:Active (exists now) ; Speaker:Boehringer-Ingleheim:Active (exists now) ; Speaker:Lilly:Active (exists now) ; Speaker:Novo Nordisk:Active (exists now) ; Researcher:Novartis:Active (exists now) ; Researcher:Amgen:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Inflammation and Atherosclerosis: Smoldering Threat or Therapeutic Target?

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Debate: Seeing the Fire or Measuring the Smoke? The Battle for Superior Risk Stratification: Imaging Biomarkers

Weber Brittany, Blankstein Ron

Debate – Colchicine for ASCVD: A Game-Changer or a Niche Therapy? Colchicine 0 not quite yet

Polonsky Tamar, Mcevoy John

More abstracts from these authors:
Coronary Calcium Density Parameters Improve Cardiovascular Risk Prediction beyond Agatston Score in Adults Aged 75 and Older: The Atherosclerosis Risk in Communities (ARIC) Study

Liu Hairong, Mok Yejin, Shah Amil, Chen Lin Yee, Budoff Matthew, Blaha Michael, Matsushita Kunihiro

Independent positive associations of coronary calcium density and volume with incident cardiovascular events in the 75-and-older population: The Atherosclerosis Risk in Communities (ARIC) Study

Liu Hairong, Mok Yejin, Shah Amil, Chen Lin, Budoff Matthew, Blaha Michael, Matsushita Kuni

You have to be authorized to contact abstract author. Please, Login
Not Available